Ahmad Alkheder
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ahmad Alkheder has a total of 200 co-authors. Here are the top co-authors by number of shared publications:
- Adel Azar
Damascus University
17 shared publications Abdulmajeed Yousfan
Damascus University
10 shared publicationsAdel Azar
Faculty of Medicine, Damascus University, Damascus, Syria
10 shared publicationsAhmad Mustafa
Damascus University
8 shared publicationsAdham Bader Aldeen Mohsen
Department of Otorhinolaryngology, Al-Mouwasat University Hospital, Damascus University, Syria
6 shared publications- Yasser Al-Ghabra
Faculty of Medicine, Damascus University, Damascus, Syria
6 shared publications
Latest Publications
- Open Access
- 9 October 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
Sebaceous carcinoma of the neck in an elderly patient: a case report
Introduction: Sebaceous carcinoma (SC) is a rare, aggressive malignancy that occurs predominantly in the periocular region. Extraocular presentations, particularly as an isolated neck mass, are exceptionally uncommon. Case presentation: An 89-year-old man presented with a 5-month history of a progressively enlarging left neck mass, which demonstrated rapid growth and ulceration in the final month. Physical examination revealed a 5-cm, clinically ill-defined, ulcerated mass over the sternocleidomastoid muscle. Imaging identified a hypervascular nodule. The patient underwent wide local excision with 2 cm safety margins. Histopathological analysis confirmed a 10-cm SC with free margins and no lymphovascular or perineural invasion. The multidisciplinary tumor board recommended no adjuvant therapy. The patient recovered well and remained disease-free at the 12-month follow-up. Discussion: This case exemplifies an extremely rare localization of SC. It underscores the critical importance of including SC in the differential diagnosis of atypical head and neck masses, as clinical and radiological features are non-specific. The definitive diagnosis relies on histopathology. The successful outcome following surgery alone highlights that wide local excision with clear margins is the cornerstone of treatment, and in this case, adjuvant therapy was withheld given favorable pathological features, although longer follow-up is necessary to confirm long-term disease control, even for large tumors. Conclusion: This report reinforces the diagnostic challenge of extraocular SC and demonstrates that curative outcomes can be achieved with surgical management tailored to histopathological findings. Long-term follow-up remains essential.
- 9 October 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
Open AccessSebaceous carcinoma of the neck in an elderly patient: a case report
Introduction: Sebaceous carcinoma (SC) is a rare, aggressive malignancy that occurs predominantly in the periocular region. Extraocular presentations, particularly as an isolated neck mass, are exceptionally uncommon. Case presentation: An 89-year-old man presented with a 5-month history of a progressively enlarging left neck mass, which demonstrated rapid growth and ulceration in the final month. Physical examination revealed a 5-cm, clinically ill-defined, ulcerated mass over the sternocleidomastoid muscle. Imaging identified a hypervascular nodule. The patient underwent wide local excision with 2 cm safety margins. Histopathological analysis confirmed a 10-cm SC with free margins and no lymphovascular or perineural invasion. The multidisciplinary tumor board recommended no adjuvant therapy. The patient recovered well and remained disease-free at the 12-month follow-up. Discussion: This case exemplifies an extremely rare localization of SC. It underscores the critical importance of including SC in the differential diagnosis of atypical head and neck masses, as clinical and radiological features are non-specific. The definitive diagnosis relies on histopathology. The successful outcome following surgery alone highlights that wide local excision with clear margins is the cornerstone of treatment, and in this case, adjuvant therapy was withheld given favorable pathological features, although longer follow-up is necessary to confirm long-term disease control, even for large tumors. Conclusion: This report reinforces the diagnostic challenge of extraocular SC and demonstrates that curative outcomes can be achieved with surgical management tailored to histopathological findings. Long-term follow-up remains essential.
- Open Access
- 21 August 2026
- Published by SAGE Publications in Ear, Nose & Throat Journal
Intralesional Triamcinolone after Needle Aspiration in Auricular Pseudocyst: A Series of Seven Cases
Introduction: Auricular pseudocyst is an uncommon, benign cartilaginous condition that often recurs after simple aspiration. Methods: We reviewed seven patients treated at a single clinic with complete aspiration followed by injection of a fixed volume of 1 mL intralesional triamcinolone (40 mg/mL) into the evacuated cavity, without local anesthesia or pressure dressings, and with routine oral ciprofloxacin. The series included six men and one woman aged 9 to 46 years. All lesions involved the scaphoid and/or triangular fossa. Patients received two or three weekly injections. Results: Two patients who developed late recurrence at six months received one additional supportive injection each. Over follow-up periods ranging from four months to one year, all seven patients achieved complete resolution. Mild skin laxity occurred in two patients, but no perichondritis, cauliflower deformity, or other major complications were observed. Conclusion: Our findings suggest that aspiration followed by intralesional triamcinolone without compression is a simple and well-tolerated outpatient treatment for selected auricular pseudocysts. Patients should be advised to avoid ongoing trauma to minimize late recurrence. Larger comparative studies are warranted.
- 21 August 2026
- Published by SAGE Publications in Ear, Nose & Throat Journal
Open AccessIntralesional Triamcinolone after Needle Aspiration in Auricular Pseudocyst: A Series of Seven Cases
Introduction: Auricular pseudocyst is an uncommon, benign cartilaginous condition that often recurs after simple aspiration. Methods: We reviewed seven patients treated at a single clinic with complete aspiration followed by injection of a fixed volume of 1 mL intralesional triamcinolone (40 mg/mL) into the evacuated cavity, without local anesthesia or pressure dressings, and with routine oral ciprofloxacin. The series included six men and one woman aged 9 to 46 years. All lesions involved the scaphoid and/or triangular fossa. Patients received two or three weekly injections. Results: Two patients who developed late recurrence at six months received one additional supportive injection each. Over follow-up periods ranging from four months to one year, all seven patients achieved complete resolution. Mild skin laxity occurred in two patients, but no perichondritis, cauliflower deformity, or other major complications were observed. Conclusion: Our findings suggest that aspiration followed by intralesional triamcinolone without compression is a simple and well-tolerated outpatient treatment for selected auricular pseudocysts. Patients should be advised to avoid ongoing trauma to minimize late recurrence. Larger comparative studies are warranted.
- Open Access
- 12 August 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (9) , 3799-3802
Septochoanal polyp: a case report and literature review
Introduction and importance: The septochoanal polyp is an exceptionally rare variant of a choanal polyp, distinguished by its origin from the nasal septum rather than the paranasal sinuses. To our knowledge, fewer than fifteen cases of true septochoanal polyps have been reported to date. Presentation of the case: A 65-year-old male presented with persistent right-sided nasal obstruction and hyponasality despite prior septal surgery. Nasal endoscopy revealed a large anterior septal perforation and a substantial polypoid lesion extending into the nasopharynx. Computed tomography confirmed a homogeneous mass originating from the superior nasal septum, with no sinus involvement. The patient underwent successful, complete endoscopic excision of the lesion, which was delivered transorally because of its size. Clinical discussion: This case contributes to the scarce literature on this rare entity. The patient’s history of septal surgery and the subsequent perforation support the theory that mechanical stress and turbulent nasal airflow may be significant factors in the pathogenesis of septal-origin polyps. Endoscopic surgery, entailing complete removal of the polyp along with its pedicle and a small mucosal margin, is the definitive treatment, resulting in a low recurrence rate and an excellent prognosis. Conclusion: The septochoanal polyp, while rare, should be considered in the differential diagnosis of a unilateral choanal mass. A combination of endoscopic examination and computed tomography is essential for precise preoperative localization of its septal origin. Endoscopic surgical excision remains the treatment of choice, offering a definitive cure. This case further highlights the potential role of disrupted nasal aerodynamics in the development of this unusual polyp.
- 12 August 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (9) , 3799-3802
Open AccessSeptochoanal polyp: a case report and literature review
Introduction and importance: The septochoanal polyp is an exceptionally rare variant of a choanal polyp, distinguished by its origin from the nasal septum rather than the paranasal sinuses. To our knowledge, fewer than fifteen cases of true septochoanal polyps have been reported to date. Presentation of the case: A 65-year-old male presented with persistent right-sided nasal obstruction and hyponasality despite prior septal surgery. Nasal endoscopy revealed a large anterior septal perforation and a substantial polypoid lesion extending into the nasopharynx. Computed tomography confirmed a homogeneous mass originating from the superior nasal septum, with no sinus involvement. The patient underwent successful, complete endoscopic excision of the lesion, which was delivered transorally because of its size. Clinical discussion: This case contributes to the scarce literature on this rare entity. The patient’s history of septal surgery and the subsequent perforation support the theory that mechanical stress and turbulent nasal airflow may be significant factors in the pathogenesis of septal-origin polyps. Endoscopic surgery, entailing complete removal of the polyp along with its pedicle and a small mucosal margin, is the definitive treatment, resulting in a low recurrence rate and an excellent prognosis. Conclusion: The septochoanal polyp, while rare, should be considered in the differential diagnosis of a unilateral choanal mass. A combination of endoscopic examination and computed tomography is essential for precise preoperative localization of its septal origin. Endoscopic surgical excision remains the treatment of choice, offering a definitive cure. This case further highlights the potential role of disrupted nasal aerodynamics in the development of this unusual polyp.
- Open Access
- 12 August 2026
- Published by SAGE Publications in Ear, Nose & Throat Journal
Patterns and Management of Complications in Elective Septoplasty: A Prospective Longitudinal Study
Objective: To prospectively document the incidence, characteristics, and management of intraoperative and postoperative complications in elective septoplasty performed by supervised residents at a university teaching hospital. Methods: This prospective longitudinal study enrolled 173 consecutive American Society of Anesthesiologists (ASA) class I patients (age 18–60 years) undergoing elective septoplasty at Al-Mouwasat University Hospital, Damascus. Procedures were performed by residents (PGY 3–4) under continuous attending supervision using the closed Killian technique. Postoperative care included intranasal packing removed on day 2 and Silastic splints removed on day 7, with monthly clinical follow-up for 3 months. Results: The cohort was predominantly male (111/173, 64.2%) with a mean age of 26.01 ± 7.65 years. Mean operative duration was 69.84 ± 23.46 minutes and mean intraoperative blood loss 151.45 ± 97.72 mL. Mucosal lacerations occurred in 139 patients (80.3%), of whom 84.9% required no intervention and 15.1% underwent suturing. Intraoperative bleeding resolved within 10 minutes in all but two cases (1.2%), which required electrocoagulation. Laceration size strongly correlated with blood loss (r = 0.634, p < 0.01). Over three months, no patient developed septal perforation, adhesions, postoperative hemorrhage requiring intervention, abscess, or cerebrospinal fluid leak. Minor events included nasal vestibulitis in two patients (1.16%) and postoperative vomiting in nine (5.2%). Conclusion: Despite an 80.3% mucosal laceration rate, no major postoperative complication occurred. Prompt intraoperative recognition and selective repair of mucosal tears, rather than their avoidance, appears sufficient to prevent long-term sequelae, even in a supervised resident training setting.
- 12 August 2026
- Published by SAGE Publications in Ear, Nose & Throat Journal
Open AccessPatterns and Management of Complications in Elective Septoplasty: A Prospective Longitudinal Study
Objective: To prospectively document the incidence, characteristics, and management of intraoperative and postoperative complications in elective septoplasty performed by supervised residents at a university teaching hospital. Methods: This prospective longitudinal study enrolled 173 consecutive American Society of Anesthesiologists (ASA) class I patients (age 18–60 years) undergoing elective septoplasty at Al-Mouwasat University Hospital, Damascus. Procedures were performed by residents (PGY 3–4) under continuous attending supervision using the closed Killian technique. Postoperative care included intranasal packing removed on day 2 and Silastic splints removed on day 7, with monthly clinical follow-up for 3 months. Results: The cohort was predominantly male (111/173, 64.2%) with a mean age of 26.01 ± 7.65 years. Mean operative duration was 69.84 ± 23.46 minutes and mean intraoperative blood loss 151.45 ± 97.72 mL. Mucosal lacerations occurred in 139 patients (80.3%), of whom 84.9% required no intervention and 15.1% underwent suturing. Intraoperative bleeding resolved within 10 minutes in all but two cases (1.2%), which required electrocoagulation. Laceration size strongly correlated with blood loss (r = 0.634, p < 0.01). Over three months, no patient developed septal perforation, adhesions, postoperative hemorrhage requiring intervention, abscess, or cerebrospinal fluid leak. Minor events included nasal vestibulitis in two patients (1.16%) and postoperative vomiting in nine (5.2%). Conclusion: Despite an 80.3% mucosal laceration rate, no major postoperative complication occurred. Prompt intraoperative recognition and selective repair of mucosal tears, rather than their avoidance, appears sufficient to prevent long-term sequelae, even in a supervised resident training setting.
- Open Access
- 24 July 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (30) , e49898
Intravascular papillary endothelial hyperplasia (Masson’s tumor) of the parotid gland: a case report and literature review
Background: Intravascular papillary endothelial hyperplasia (IPEH), or Masson’s tumor, is a rare benign vascular proliferation that uncommonly involves the parotid gland. Methods: This report details the case of a 53-year-old female who presented with an 8-year history of a right parotid mass that exhibited significant growth over 2 years, accompanied by the development of multiple bluish cutaneous lesions in the subauricular and cervical region. Results: Clinical and radiological evaluations were nonspecific. A cutaneous biopsy revealed a cavernous hemangioma. The patient underwent a superficial parotidectomy with complete facial nerve preservation. Histopathological examination of the parotid specimen confirmed a diagnosis of IPEH, characterized by papillary fronds lined by bland endothelial cells. Notably, one of the excised skin lesions also showed histological features of IPEH, alongside hemangioma. Conclusion: This case is exceptional as it represents a mixed-form IPEH arising in association with a preexisting vascular lesion and demonstrates rare multifocal involvement of both the parotid gland and the skin. It underscores the diagnostic challenge this entity poses, often mimicking other salivary gland tumors, and highlights histopathology as the diagnostic cornerstone. Complete surgical excision remains the treatment of choice and is curative. This case contributes to the limited literature on parotid IPEH and illustrates its potential for multifocal presentation in the context of underlying vascular pathology, making this the seventh documented case in the literature.
- 24 July 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (30) , e49898
Open AccessIntravascular papillary endothelial hyperplasia (Masson’s tumor) of the parotid gland: a case report and literature review
Background: Intravascular papillary endothelial hyperplasia (IPEH), or Masson’s tumor, is a rare benign vascular proliferation that uncommonly involves the parotid gland. Methods: This report details the case of a 53-year-old female who presented with an 8-year history of a right parotid mass that exhibited significant growth over 2 years, accompanied by the development of multiple bluish cutaneous lesions in the subauricular and cervical region. Results: Clinical and radiological evaluations were nonspecific. A cutaneous biopsy revealed a cavernous hemangioma. The patient underwent a superficial parotidectomy with complete facial nerve preservation. Histopathological examination of the parotid specimen confirmed a diagnosis of IPEH, characterized by papillary fronds lined by bland endothelial cells. Notably, one of the excised skin lesions also showed histological features of IPEH, alongside hemangioma. Conclusion: This case is exceptional as it represents a mixed-form IPEH arising in association with a preexisting vascular lesion and demonstrates rare multifocal involvement of both the parotid gland and the skin. It underscores the diagnostic challenge this entity poses, often mimicking other salivary gland tumors, and highlights histopathology as the diagnostic cornerstone. Complete surgical excision remains the treatment of choice and is curative. This case contributes to the limited literature on parotid IPEH and illustrates its potential for multifocal presentation in the context of underlying vascular pathology, making this the seventh documented case in the literature.
- Open Access
- 22 July 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (8) , 2741-2747
Ballistic head and neck injuries: management rationale and outcomes in a case series
Introduction: Penetrating head and neck injuries with retained foreign bodies pose significant management challenges due to the anatomical density of vital structures. The optimal therapeutic strategy – ranging from surgical extraction to conservative observation – remains guided by individual patient and injury characteristics. Methods: This case series retrospectively reviews four distinct presentations of retained metallic foreign bodies in the head and neck region. Diagnostic evaluation utilized advanced computed tomography (CT) for precise localization. Management strategies were individualized, including functional endoscopic sinus surgery, open surgical exploration via parotid and cervical approaches, and active observation. Results: CT imaging was critical for preoperative planning in all symptomatic cases, accurately defining the relationship of fragments to neurovascular structures. Endoscopic retrieval was successful for a fragment within an Onodi cell. Open approaches were required for fragments embedded in the parotid region and deep neck, with one patient developing Frey syndrome postoperatively. In an asymptomatic patient with no structural compromise, observation was safely elected. Delayed complications, including chronic pain and infection, manifested years after the initial injury in two cases. Conclusions: Management of penetrating head and neck foreign bodies requires a tailored, multidisciplinary approach. Advanced imaging is indispensable for risk assessment and planning. Treatment should be individualized, with minimally invasive techniques preferred when feasible, while observation is a valid option in select asymptomatic patients. Long-term follow-up is essential due to the potential for delayed sequelae.
- 22 July 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (8) , 2741-2747
Open AccessBallistic head and neck injuries: management rationale and outcomes in a case series
Introduction: Penetrating head and neck injuries with retained foreign bodies pose significant management challenges due to the anatomical density of vital structures. The optimal therapeutic strategy – ranging from surgical extraction to conservative observation – remains guided by individual patient and injury characteristics. Methods: This case series retrospectively reviews four distinct presentations of retained metallic foreign bodies in the head and neck region. Diagnostic evaluation utilized advanced computed tomography (CT) for precise localization. Management strategies were individualized, including functional endoscopic sinus surgery, open surgical exploration via parotid and cervical approaches, and active observation. Results: CT imaging was critical for preoperative planning in all symptomatic cases, accurately defining the relationship of fragments to neurovascular structures. Endoscopic retrieval was successful for a fragment within an Onodi cell. Open approaches were required for fragments embedded in the parotid region and deep neck, with one patient developing Frey syndrome postoperatively. In an asymptomatic patient with no structural compromise, observation was safely elected. Delayed complications, including chronic pain and infection, manifested years after the initial injury in two cases. Conclusions: Management of penetrating head and neck foreign bodies requires a tailored, multidisciplinary approach. Advanced imaging is indispensable for risk assessment and planning. Treatment should be individualized, with minimally invasive techniques preferred when feasible, while observation is a valid option in select asymptomatic patients. Long-term follow-up is essential due to the potential for delayed sequelae.
- 17 July 2026
- Published by Springer Nature in Infection
- Vol. 54 (5) , 2511-2530
Comparative immunogenicity and safety of PCV15 versus PCV13 for pneumococcal serotypes 22 F and 33 F: a systematic review and meta-analysis with meta-regression
Background Streptococcus pneumoniae remains a major cause of morbidity and mortality worldwide, particularly among children and older adults. Although 13-valent pneumococcal conjugate vaccine (PCV13) significantly reduced the burden of pneumococcal disease, non-PCV13 serotypes such as 22 F and 33 F continue to cause invasive pneumococcal disease (IPD). PCV15 was developed to address this gap by including serotypes 22 F and 33 F. Methods Following PRISMA guidelines, a comprehensive literature search was conducted across multiple databases through March 2024. Randomized controlled trials (RCTs) comparing PCV15 and PCV13 were included. Primary outcomes included IgG geometric mean concentrations (GMCs) and opsonophagocytic activity geometric mean titers (OPA GMTs) for serotypes 22 F and 33 F. Results Nineteen RCTs (n = 16,046) were included. PCV15 demonstrated significantly higher immunogenicity than PCV13 for serotypes 22 F and 33 F across most age and dose subgroups. For IgG GMCs, pooled mean differences (MDs) for serotype 22 F were 6.34 (95% CI 5.13–7.56; I²=97%) in infants, 10.09 (95% CI 6.06–14.13; I²=92%) in children, and 3.19 (95% CI 2.01–4.36; I²=96%) in adults. For serotype 33 F, MDs were 2.40 (95% CI 1.52–3.28; I²=99%), 4.27 (95% CI 3.74–4.80; I²=0%), and 6.81 (95% CI 5.10–8.52; I²=93%), respectively. OPA GMTs also favored PCV15 for serotype 22 F after both single-dose (MD = 1.55, 95% CI 0.69–2.41; I²=99%) and three-dose schedules (MD = 1.66, 95% CI 1.24–2.08; I²=87%), while for serotype 33 F, superiority was observed only with three doses (MD = 0.98, 95% CI 0.56–1.39; I²=90%). PCV15 was associated with higher rates of injection-site adverse events (RR = 1.08, 95% CI 1.03–1.11), whereas systemic adverse events were comparable between groups (RR = 1.03, 95% CI 1.00–1.06). Meta-regression identified a significant negative association between age and IgG GMC 22 F (β=-0.061, 95% CI -0.096 to -0.025; p ≤ 0.001). Certainty of evidence ranged from low to moderate according to GRADE assessment, primarily limited by inconsistency across studies. Conclusion PCV15 demonstrated significantly higher immunogenicity against serotypes 22 F and 33 F than PCV13 across most age and dose subgroups while maintaining a generally comparable safety profile. These findings support the immunogenic advantage of PCV15 for the additional serotypes included in the vaccine; however, studies evaluating clinical effectiveness are needed to determine whether these immunological differences translate into reductions in pneumococcal disease.
- 17 July 2026
- Published by Springer Nature in Infection
- Vol. 54 (5) , 2511-2530
Comparative immunogenicity and safety of PCV15 versus PCV13 for pneumococcal serotypes 22 F and 33 F: a systematic review and meta-analysis with meta-regression
Background Streptococcus pneumoniae remains a major cause of morbidity and mortality worldwide, particularly among children and older adults. Although 13-valent pneumococcal conjugate vaccine (PCV13) significantly reduced the burden of pneumococcal disease, non-PCV13 serotypes such as 22 F and 33 F continue to cause invasive pneumococcal disease (IPD). PCV15 was developed to address this gap by including serotypes 22 F and 33 F. Methods Following PRISMA guidelines, a comprehensive literature search was conducted across multiple databases through March 2024. Randomized controlled trials (RCTs) comparing PCV15 and PCV13 were included. Primary outcomes included IgG geometric mean concentrations (GMCs) and opsonophagocytic activity geometric mean titers (OPA GMTs) for serotypes 22 F and 33 F. Results Nineteen RCTs (n = 16,046) were included. PCV15 demonstrated significantly higher immunogenicity than PCV13 for serotypes 22 F and 33 F across most age and dose subgroups. For IgG GMCs, pooled mean differences (MDs) for serotype 22 F were 6.34 (95% CI 5.13–7.56; I²=97%) in infants, 10.09 (95% CI 6.06–14.13; I²=92%) in children, and 3.19 (95% CI 2.01–4.36; I²=96%) in adults. For serotype 33 F, MDs were 2.40 (95% CI 1.52–3.28; I²=99%), 4.27 (95% CI 3.74–4.80; I²=0%), and 6.81 (95% CI 5.10–8.52; I²=93%), respectively. OPA GMTs also favored PCV15 for serotype 22 F after both single-dose (MD = 1.55, 95% CI 0.69–2.41; I²=99%) and three-dose schedules (MD = 1.66, 95% CI 1.24–2.08; I²=87%), while for serotype 33 F, superiority was observed only with three doses (MD = 0.98, 95% CI 0.56–1.39; I²=90%). PCV15 was associated with higher rates of injection-site adverse events (RR = 1.08, 95% CI 1.03–1.11), whereas systemic adverse events were comparable between groups (RR = 1.03, 95% CI 1.00–1.06). Meta-regression identified a significant negative association between age and IgG GMC 22 F (β=-0.061, 95% CI -0.096 to -0.025; p ≤ 0.001). Certainty of evidence ranged from low to moderate according to GRADE assessment, primarily limited by inconsistency across studies. Conclusion PCV15 demonstrated significantly higher immunogenicity against serotypes 22 F and 33 F than PCV13 across most age and dose subgroups while maintaining a generally comparable safety profile. These findings support the immunogenic advantage of PCV15 for the additional serotypes included in the vaccine; however, studies evaluating clinical effectiveness are needed to determine whether these immunological differences translate into reductions in pneumococcal disease.